Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS-Reference-Cited by-同舟云学术

Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS

Published:2009-06 Issue:6 Volume:8 Page:705-716
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Autran Brigitte,Asturias Edwin J,Evans Stephen,Hartigan-Go Kenneth,Hussey Gregory,John T Jacob,Lambert Paul-Henri,Law Barbara,Midthun Karen,Nohynek Hanna,Salmaso Stefania,Smith Peter G,Zuber Patrick LF,Bentsi-Enchill Adwoa,Caric Aleksandra,Pfeifer Dina,Duclos Philippe,Wood David

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

http://www.tandfonline.com/doi/pdf/10.1586/erv.09.40

Reference78 articles.

1. Institute of Medicine. Evidence concerning pertussis vaccines and other illnesses and conditions. In:Adverse Effects of Pertussis and Rubella Vaccines. Howson CP, Howe CJ, Fineberg HV (Eds). Institute of Medicine, Washington, DC, USA 144–186 (1991).

2. Rash after measles vaccination: laboratory analysis of cases reported in São Paulo, Brazil

3. Vogel FR, Hem SL. Immunologic adjuvants. In:Vaccines (4th Edition). Plotkin SA, Orenstein WA (Eds). Elsevier, Philadelphia, PA, USA 69–79 (2004).

4. Finn TM, Egan W. Vaccine additives and manufacturing residuals in United States-licensed vaccines. In:Vaccines (4th Edition). Plotkin SA, Orenstein WA (Eds). Elsevier, Philadelphia, PA, USA 81–90 (2004).

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving the quality of quantitative polymerase chain reaction experiments: 15 years of MIQE;Molecular Aspects of Medicine;2024-04

2. Menstrual disorders following COVID-19 vaccination: a review using a systematic search;Frontiers in Drug Safety and Regulation;2024-01-31

3. A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID‐19 mRNA vaccination;British Journal of Clinical Pharmacology;2022-12-26

4. Vaccine events raising public concern and associated immunization program policy and practice changes, China, 2005–2021;Vaccine;2022-04

5. COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials;Expert Review of Vaccines;2021-06-15